About
Guided by our values, we are an impact-driven organization that improves care in every setting – one product, one partner, one patient at a time.
Guided by our values, we are an impact-driven organization that improves care in every setting – one product, one partner, one patient at a time.
Through our core commitments, we are leveraging our scale for the greater good, such as serving the needs of our stakeholders, donating back to our communities, protecting our planet, working with policymakers, and more.
Every year, we publish updates to our commitments through our Impact Report.
Download Our Impact ReportOur businesses bring together leading technologies, innovative solutions and hands-on expertise to support the entire healthcare ecosystem.
We distribute pharmaceuticals and medical supplies to healthcare settings across North America, from pharmacies and hospitals to doctors’ offices and clinics.
We help to ensure the financial wellbeing of pharmacies and health systems and support a stable work environment for their employees.
We provide research, insights, technologies and other support to help address challenges in cancer and specialty care.
We provide a suite of solutions designed to address access, affordability and adherence challenges by bridging the gaps between biopharma companies, pharmacies, providers, and payers to help patients get on and stay on their medications.
We offer solutions that enable employers, payers, health-plan brokers and government agencies to provide lower-cost options for prescription medications and therapies.
We help to ensure the financial wellbeing of pharmacies and health systems and support a stable work environment for their employees.
Every year, we publish updates to our commitments through our Impact Report.
Download Our Impact ReportLearn how we help accelerate innovative therapy launches so providers can access them when and where patients need them most.
Read Time
1.5 minutes
Key Points
How does McKesson help accelerate new therapy launches?
McKesson helps accelerate new therapy launches through distribution scale, provider access and commercialization support that help innovative therapies reach care teams quickly and reliably.
Who you’ll hear from:
About Always Advancing
From navigating the stages of research and development and engaging diverse populations in clinical trials to enabling patient access to prescribed therapies and beyond, the healthcare landscape has never been more complex or more promising for improving the lives of patients.
Our Always Advancing series shares how we help our biopharma partners bridge the divide between today’s challenges and tomorrow’s breakthroughs so more patients can get the care they need.
McKesson supports healthcare providers and partners to improve access, strengthen local care, and help ensure medications reach patients in communities nationwide.
McKesson’s GPOs empower independent healthcare providers to access differentiated contract pricing and terms, navigate rising drug costs and sustain community-based care.
Leveraging data from the largest community oncology networks, we look at factors increasing colorectal cancer in younger patients.
How treatment centers can access CGTs through two different channel strategies — Buy-and-Bill and Specialty Pharmacy.
Discover how coordinated rare disease care simplifies complex workflows, supports providers with specialty pharmacy services, and improves the patient journey.
Discover how InspiroGene by McKesson is collaborating with Biologics by McKesson to streamline cell and gene therapy delivery and accelerate patient access to treatments.
The efforts and innovations enabling local cancer care practices to provide advanced, personalized therapies close to patients’ homes
Biopharma and community oncology must unite in a new patient reality.
Discover how The US Oncology Network leverages AI to reduce provider burden, extract clinical data and improve patient outcomes.